CoChat

Clinical Efficacy and Toxicity of Anti-EGFR Therapy in Common Cancers

Open access
Harandi, Amir, Zaidi, Aisha S., Stocker, Abigail M., Laber, Damian A. · 2009 · Journal of Oncology
Cited by 116

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Epidermal growth factor receptor (EGFR) is a cell surface molecule and member of the ErbB family of receptor tyrosine kinases. Its activation leads to proliferation, antiapoptosis, and metastatic spread, making inhibition of this pathway a compelling target. In recent years, an increasing number of clinical trials in the management of solid malignancies have become available indicating the clinical efficacy of anti-EGFR monoclonal antibodies and oral small molecule tyrosine kinase inhibitors (TKIs). This review addresses frequently used EGFR inhibitors, summarizes clinical efficacy data of these new therapeutic agents, and discusses their associated toxicity and management.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2009/567486

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 116

Metadata

Authors
Harandi, A., Zaidi, A. S., Stocker, A. M., & Laber, D. A.
Venue
Journal of Oncology
Published
2009
Volume
2009
Pages
1-14
ISSN
  • 1687-8450 (ISSN-L)
  • 1687-8469
OpenAlex
W2034287995
Cited by
116
References
16
FWCI
3.43
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical Efficacy and Toxicity of Anti-EGFR Therapy in Common Cancers. https://app.cochat.ai/papers/10.1155/2009/567486
The paper
Harandi, A., Zaidi, A. S., Stocker, A. M., & Laber, D. A. (2009). Clinical Efficacy and Toxicity of Anti-EGFR Therapy in Common Cancers. Journal of Oncology. https://doi.org/10.1155/2009/567486

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.